# Effect of Basal-Bolus Closed-Loop Co-Administration of Insulin and Pramlintide on Improving the Glycemic Control in Type 1 Diabetes

> **NCT02814123** · PHASE2 · COMPLETED · sponsor: **McGill University** · enrollment: 28 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **OTHER:** 24-hour inpatient intervention

## Key facts

- **NCT ID:** NCT02814123
- **Lead sponsor:** McGill University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-13
- **Primary completion:** 2018-07-08
- **Final completion:** 2018-07-08
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2020-02-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02814123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02814123, "Effect of Basal-Bolus Closed-Loop Co-Administration of Insulin and Pramlintide on Improving the Glycemic Control in Type 1 Diabetes". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02814123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*